Filters
A 16-year longitudinal epidemiologic study has found low rates of disseminated candidiasis and low mortality associated with candidemia at a tertiary paediatric hospital.
In patients with COVID-19, starting remdesivir within 9 days of symptom onset confers benefit for survival, according to a study.
A small phase III trial has found that ceftobiprole is well tolerated and as efficacious as standard-of-care (SoC) cephalosporins in paediatric patients with hospital- (HAP) or community-acquired pneumonia (CAP) requiring hospitalization.
By itself, chronic hepatitis B infection compromises bone health by increasing bone resorption, regardless of the use of antiretroviral drugs, a recent study has found.
